Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alvotech

8.63
-0.1000-1.15%
Post-market: 8.880.2500+2.90%16:56 EDT
Volume:235.52K
Turnover:2.04M
Market Cap:2.69B
PE:25.46
High:8.84
Open:8.75
Low:8.54
Close:8.73
Loading ...

Alvotech Sa - to Explore Listing of Swedish Depository Receipts on Nasdaq Stockholm

THOMSON REUTERS
·
20 Mar

Alvotech Acquires Xbrane’s R&D Operations in Sweden and Further Affirms its Global Leadership Position in Biosimilars Development and Production

GlobeNewswire
·
20 Mar

FDA Accepts RDY & ALVO's Prolia & Xgeva Biosimilar BLA for Review

Zacks
·
19 Mar

BRIEF-Alvotech, Dr. Reddy's Announce FDA Acceptance Of Biologic License Application

Reuters
·
18 Mar

Dr. Reddy's, Alvotech Say FDA Accepts Biologic License Application for Bone Drug Biosimilar

MT Newswires Live
·
18 Mar

Dr. Reddy’s, Alvotech announce FDA acceptance of BLA for AVT03

TIPRANKS
·
18 Mar

Alvotech and Dr. Reddy’s Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®

GlobeNewswire
·
18 Mar

Alvotech Meeting Investors and Participates in Fireside Chat At Barclays 27th Global Healthcare Conference in Miami, Florida

GlobeNewswire
·
07 Mar

J&J sues Samsung Bioepis over contract breach for Stelara biosimilar

Reuters
·
25 Feb

Alvotech Launches SELARSDI Biosimilar in U.S. Market

TIPRANKS
·
24 Feb

Alvotech to Report Full Year Financial Results for 2024 on March 26, 2025, and Hosts Conference Call on March 27, 2025, at 8:00 am ET

GlobeNewswire
·
24 Feb

BUZZ-Alvotech rallies after US biosimilar launch

Reuters
·
22 Feb

Alvotech Sa Shares Rise 5.6% After Co and Teva Pharma Launch Biosimilar to J&J's Stelara in US

THOMSON REUTERS
·
22 Feb

Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Friday Amid Ongoing Tariff Uncertainties

MT Newswires Live
·
21 Feb

Teva Pharmaceutical US Affiliate, Alvotech Selarsdi Injection Now Available in US

MT Newswires Live
·
21 Feb

Teva Pharma and Alvotech launch biosimilar to J&J's Stelara in US

Reuters
·
21 Feb

Teva Pharma and Alvotech launch Stelara biosimilar in US

Reuters
·
21 Feb

BRIEF-Teva And Alvotech Announce Selarsdi™ Injection Now Available In The U.S.

Reuters
·
21 Feb

Teva and Alvotech Announce Selarsdi™ (Ustekinumab-Aekn) Injection NOW Available in the U.S.

THOMSON REUTERS
·
21 Feb

Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.

GlobeNewswire
·
21 Feb